Designing receptor agonists with enhanced pharmacokinetics by grafting macrocyclic peptides into fragment crystallizable regions
Katsuya Sakai(Kanazawa University), Kunio Matsumoto(Kanazawa University)
Cited by 16
Related Papers
Different growth and metastatic phenotypes associated with a cell-intrinsic change of Met in metastatic melanoma
|Oncotarget|2016|26
Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion
|Scientific Reports|2020|12
MET Activation by a Macrocyclic Peptide Agonist that Couples to Biological Responses Differently from HGF in a Context-Dependent Manner
|International Journal of Molecular Sciences|2018|6
Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation
|International Journal of Molecular Sciences|2021|5